GlassScriptPhysician profile
Greg M Wilkinson
NPI 1316146939
$4,233.79
in general payments reported to CMS, 2019-2025
23 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $320 · 2022: $746 · 2023: $2,772 · 2024: $230 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,955 · Food and Beverage: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,954.52 |
| Food and Beverage | $1,213.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $2,227.75 | 2023 | Iovera, Zilretta |
| Abbvie INC. | $653.73 | 2021-2025 | |
| Nevro Corp. | $224.63 | 2021-2023 | Senza |
| Medtronic, INC. | $210.01 | 2021-2025 | Intellis Adaptivestim, Accurian |
| Biohaven Pharmaceutical Holding Company LTD. | $111.33 | 2022 | |
| Grt US Holding, INC. | $111.24 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $88.08 | 2021-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.65 | 2021-2025 | Relistor |
| Abbott Laboratories | $73.70 | 2023 | Proclaim |
| Vertos Medical, INC. | $69.97 | 2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $54.77 | 2025 | |
| Pfizer INC. | $54.28 | 2023-2024 | |
| Averitas Pharma INC. | $46.88 | 2023-2024 | Qutenza |
| Organogenesis INC. | $38.24 | 2021-2022 | |
| Amgen INC. | $37.24 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $28.16 | 2021 | |
| Lilly USA, LLC | $24.98 | 2023 | Emgality |
| Si-Bone, INC. | $24.44 | 2022 | |
| Piramal Critical Care | $16.45 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.98 | 2021 | |
| Idorsia Pharmaceuticals US INC | $15.50 | 2022 | |
| Tactile Systems Technology INC | $15.48 | 2022 | |
| Allergan, INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.